Flinders Medical Center

Bedford Park, South Australia 5042

2 studies enrolling now · 7 studies all time

What they study most

Advanced Malignant Neoplasm, Advanced Solid Tumor, Angioimmunoblastic T-cell Lymphoma, Breast Cancer, Colorectal Cancer, Drug Resistant Partial Onset Seizure, ER/PR Positive Breast Cancer, ER/PR(+), Her2(-) Breast Cancer, Endometrial Cancer, Follicular T-Cell Lymphoma, Gall Bladder Cancer, HER2+ Breast Cancer

Studies at this site

• The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) — Recruiting now
• Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma — Recruiting now
• Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS) — Stopped early
• Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension — Completed
• Pralatrexate vs Observation Following CHOP-based Chemotherapy in Undiagnosed Peripheral T-cell Lymphoma Patients — Stopped early
• Ibrutinib With Rituximab in Adults With Waldenström's Macroglobulinemia — Completed
• Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas — Completed